UPDATED Jan 01, 2026
Discover Canadian Pharmaceuticals & Biotech Growth Stocks that are on the TSX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HITI | CA$3.67 | -5.7% | -17.0% | CA$314.5m | CA$7.75 | PB2.3x | E210.1% | n/a | ||
OGI | CA$2.31 | -4.1% | 0.4% | CA$313.2m | CA$3.40 | PS1.2x | E145.5% | n/a | ||
DHB | CA$0.20 | -6.8% | 17.1% | CA$6.4m | n/a | PB1.5x | E136.9% | n/a | ||
WEED | CA$1.56 | -12.4% | -60.4% | CA$544.1m | CA$3.76 | PS1.9x | E127.3% | n/a | ||
ACB | CA$5.77 | -8.0% | -5.6% | CA$330.6m | CA$7.80 | PB0.6x | E122.6% | n/a | ||
TRUL | CA$11.91 | 9.3% | 59.0% | CA$2.0b | CA$19.03 | PS1.2x | E122.6% | n/a | ||
XRTX | CA$0.77 | -4.9% | -53.6% | CA$5.4m | n/a | PB2x | E98.6% | n/a | ||
PLTH | CA$0.28 | -9.7% | -49.1% | CA$92.7m | n/a | PB1.2x | E86.9% | n/a | ||
LABS | CA$0.065 | -13.3% | 8.3% | CA$29.5m | n/a | PB0.7x | E86.2% | n/a | ||
TSND | CA$0.99 | -10.0% | 7.6% | CA$364.1m | CA$1.73 | PB2.3x | E81.1% | n/a | ||
VEXT | CA$0.26 | -8.9% | 54.5% | CA$62.8m | n/a | PB0.7x | E81.1% | n/a | ||
VRNO | CA$1.74 | 1.8% | -1.1% | CA$592.1m | CA$4.34 | PB0.5x | E79.4% | n/a | ||
NGEN | CA$7.68 | 7.0% | 144.6% | CA$547.4m | CA$7.60 | PE-23.8x | E73.0% | n/a | ||
EDT | CA$1.44 | 13.4% | 188.0% | CA$378.8m | CA$3.10 | PS153.9x | E65.8% | n/a | ||
CURA | CA$3.41 | -9.3% | 52.2% | CA$2.7b | CA$4.91 | PS1.5x | E61.2% | n/a | ||
HLS | CA$4.82 | 0.6% | 22.6% | CA$149.5m | CA$7.82 | PS2x | E60.7% | 0% | ||
CRDL | CA$1.31 | -5.1% | -29.2% | CA$129.5m | CA$6.00 | PB13.5x | E59.0% | n/a | ||
MDP | CA$2.91 | 5.1% | -15.9% | CA$95.7m | CA$6.89 | PE180.6x | E57.5% | n/a | ||
GUD | CA$6.05 | 1.3% | 13.3% | CA$595.7m | CA$7.93 | PS1.5x | E54.0% | n/a | ||
SVA | CA$0.13 | 0% | -42.2% | CA$45.5m | CA$2.39 | PE-2.8x | E52.5% | n/a | ||
EPRX | CA$10.32 | 3.0% | 128.8% | CA$527.2m | CA$12.00 | PB6.5x | E30.7% | n/a | ||
GTII | CA$11.02 | -1.2% | -6.7% | CA$2.6b | CA$17.50 | PE42.7x | E28.6% | n/a | ||
CL | CA$1.66 | -4.6% | 25.8% | CA$732.9m | CA$2.36 | PB1x | E27.3% | n/a | ||
DB | CA$0.11 | 10.0% | 57.1% | CA$63.5m | n/a | PE5.4x | E26.0% | n/a |